Integrative Cardiac Strain Analysis Systems and Methods

This inventive concept integrates deep learning-based phase unwrapping for dense MRI with other distinct technologies, such as AI, IoT, blockchain, and new materials, to create a more powerful system for cardiac strain analysis.

The original patent addressed the limitations of myocardial strain imaging by utilizing deep learning-based phase unwrapping for dense MRI. However, this approach had limited scope and did not leverage the potential of other technologies. This new inventive concept solves this problem by synergistically combining the patented inventive concept with other distinct technologies to create a more comprehensive and powerful system for cardiac strain analysis.

The new system integrates a deep learning-based phase unwrapping module with a blockchain-based data sharing platform for secure and transparent data exchange between healthcare providers. Additionally, it utilizes an IoT-enabled wearable device for real-time monitoring of cardiac health, an AI-powered decision support module, and a new material-based MRI coil for enhanced signal quality. This synergistic combination enables more accurate and personalized cardiac strain analysis, improved data security, and enhanced patient care.

The new claims introduce novel and non-obvious combinations of the patented inventive concept with other distinct technologies, such as blockchain, IoT, AI, and new materials. These combinations provide a more comprehensive and powerful system for cardiac strain analysis, overcoming the limitations of the original patent.

Alternative embodiments may include integrating the deep learning-based phase unwrapping module with other technologies, such as cloud-based analytics platforms, patient-specific 3D printed heart models, or edge computing devices. Variations may also include using different AI architectures, IoT devices, or blockchain protocols to achieve similar goals.

This inventive concept has significant commercial potential in the healthcare industry, particularly in cardiac imaging and personalized medicine. The target market includes hospitals, research institutions, and medical device manufacturers seeking to improve cardiac strain analysis and patient care.